Related Experiment Video
Updated: Aug 26, 2026

Working with Auditory HEI-OC1 Cells
Published on: September 3, 2016
Heyneanol A induces apoptosis via cytochrome c release and caspase activation in human leukemic U937 cells
Eun-Ok Lee1, Byoung-Mog Kwon, Gyu-Yong Song
1Department of Oncology, Graduate School of East-West Medical Science, Kyung Hee University, 1 Seochunri, Kiheungeup, Yongin 449-701, South Korea. sungkim7@khu.ac.kr
Abstract:
Heyneanol A, a tetramer of resveratrol, is isolated from the roots of Vitis amurensis by cytotoxicity based fractionation. In this study, the mechanism of apoptosis by heyneanol A was evaluated in human leukemic U937 cells. Heyneanol A (IC(50) = 6.6 microM at 24 h) exhibited stronger cytotoxic effect than resveratrol (IC(50) = 100 microM at 24 h) by 15-fold on human leukemic U937 cells by XTT assay. Apoptotic bodies were observed in U937 cells treated with 6 microM of heyneanol A by TUNEL assay. Heyneanol A effectively increased the portion of sub-G(1) DNA content in a time- and concentration-dependent manner by flow cytometric analysis. Heyneanol A also induced cytochrome c release from mitochondria into the cytosol and subsequent caspase activation involving caspase 9 and 3 to cleave PARP. However, it did not affect the expressions of Bax and Bcl-2 by western blotting. It was confirmed that the activation of caspase 8, 9 and 3 and the cleavage of PARP by heyneanol A were completely blocked by adding Z-VAD-FMK, a caspase inhibitor. These findings suggest that heyneanol A has anti-tumor activity, which may be mediated by apoptosis caused by cytochrome c release and caspase activation in human leukemic U937 cells.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
The Extrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
